Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharmacogenomics. 2004 Sep;5(6):699-707.

DNA methylation biomarkers of cancer: moving toward clinical application.

Author information

  • 1Northwestern University, 710 N. Fairbanks Ct, Olson 8-424, Chicago, IL 60611, USA. levenson@northwestern.edu

Abstract

While different markers for cancer diagnosis have been known for at least a decade, the systematic search for biomarkers emerged only several years ago. In this article, I will concentrate on DNA methylation as a dynamic and robust platform for the development of cancer-specific biomarkers. Simultaneous analysis of a growing number of independent methylation events can create increasingly more precise and individualized diagnostics. The differential detection of methylated and unmethylated DNA can be accomplished through either chemical modification or digestion with methylation-sensitive restriction enzyme(s). The benefits and potential pitfalls of both these approaches for clinical sample analysis will be addressed.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk